Ability of charcoal to prevent absorption of paroxetine.
Greb
W H
WH
Beecham-Wülfing Clinical Pharmacology Research Institute, Neuss, Federal Republic of Germany.
Buscher
G
G
Dierdorf
H D
HD
von Schrader
H W
HW
Wolf
D
D
D000284:Administration, Oral; D000328:Adult; D000928:Antidepressive Agents / Q000493:pharmacokinetics*; D002606:Charcoal / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007408:Intestinal Absorption / Q000187:drug effects*; D008297:Male; D017374:Paroxetine; D010880:Piperidines / Q000493:pharmacokinetics*; D012702:Serotonin Antagonists / Q000493:pharmacokinetics*
D000928:Antidepressive Agents; D010880:Piperidines; D012702:Serotonin Antagonists; D002606:Charcoal; D017374:Paroxetine